Behavioral weight loss interventions to prevent obesity-relatedmorbidity and mortality in adults US preventive services task force recommendation statement

JAMA - Journal of the American Medical Association

Volumn 320, Issue 11, 2018, Pages 1163-1171

  Curry, Susan J ^a   Krist, Alex H ^b,c   Owens, Douglas K ^d,e   Barry, Michael J ^f   Caughey, Aaron B ^g   Davidson, Karina W ^h   Doubeni, Chyke A ⁱ   Epling, John W ^j   Grossman, David C ^k   Kemper, Alex R ^l   Kubik, Martha ^m   Landefeld, C Seth ⁿ   Mangione, Carol M ^o   Phipps, Maureen G ^p   Silverstein, Michael ^q   Simon, Melissa A ^r   Tseng, Chien Wen ^s,t   Wong, John B ^u  

^a UNIVERSITY OF IOWA   (United States)

^b Fairfax Family Practice Residency   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e STANFORD UNIVERSITY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h Columbia University ^*  (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^k KAISER PERMANENTE   (United States)

^l NATIONWIDE CHILDREN S HOSPITAL   (United States)

^m TEMPLE UNIVERSITY   (United States)

ⁿ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p BROWN UNIVERSITY   (United States)

^q BOSTON UNIVERSITY   (United States)

^r NORTHWESTERN UNIVERSITY   (United States)

^s UNIVERSITY OF HAWAII   (United States)

^t PACIFIC HEALTH RESEARCH AND EDUCATION INSTITUTE   (United States)

^u TUFTS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; LIRAGLUTIDE; LORCASERIN; NALTREXONE; PHENTERMINE PLUS TOPIRAMATE; PLACEBO; TETRAHYDROLIPSTATIN; ANTIOBESITY AGENT;

ATTITUDE TO HEALTH; BODY MASS; BODY WEIGHT MAINTENANCE; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HOSPITAL SERVICE; HUMAN; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PEER COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; UNITED STATES; UNSPECIFIED SIDE EFFECT; WEIGHT LOSS PROGRAM; ADULT; BEHAVIOR THERAPY; BODY WEIGHT LOSS; COMPLICATION; FEMALE; HEALTH BEHAVIOR; MALE; MULTIMODALITY CANCER THERAPY; OBESITY MANAGEMENT; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PROCEDURES;

ADULT; ANTI-OBESITY AGENTS; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; OBESITY; OBESITY MANAGEMENT; PREVENTIVE HEALTH SERVICES; UNITED STATES; WEIGHT LOSS;

EID: 85053495535     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.13022     Document Type: Review

References (39)

1. LeBlanc EL, Patnode CD,Webber EM, Redmond N, Rushkin M, O'Connor EA. Behavioral and PharmacotherapyWeight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the US Preventive Services Task Force: Evidence Synthesis No. 168. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 18-05239-EF-1.
2. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015; (219):1-8.
3. Bogers RP, BemelmansWJ, Hoogenveen RT, et al; BMI-CHD Collaboration Investigators. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: ameta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167(16):1720-1728. Doi:10.1001/archinte.167.16.1720
4. Colditz GA, WillettWC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122(7): 481-486. Doi:10.7326/0003-4819-122-7-199504010-00001
5. Guh DP, ZhangW, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. Doi:10.1186/1471-2458-9-88
6. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 524 million UK adults. Lancet. 2014;384(9945):755-765. Doi:10.1016/S0140-6736(14)60892-8
7. Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356:j477. Doi:10.1136/bmj.j477
8. Afshin A, Forouzanfar MH, Reitsma MB, et al; GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13-27. Doi:10.1056/NEJMoa1614362
9. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71-82. Doi:10.1001/jama.2012 .113905
10. Borrell LN, Samuel L. Body mass index categories and mortality risk in US adults: the effect of overweight and obesity on advancing death. Am J Public Health. 2014;104(3):512-519. Doi:10.2105/AJPH.2013.301597
11. Dobbins M, Decorby K, Choi BC. The association between obesity and cancer risk: ameta-analysis of observational studies from 1985 to 2011. ISRN Prev Med. 2013;2013:680536. Doi:10.5402/2013/680536
12. Whitlock G, Lewington S, Sherliker P, et al; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083-1096. Doi:10.1016/S0140-6736(09)60318-4
13. Siu AL; U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(11):861-868. Doi:10.7326/M15-2345
14. Siu AL; U.S. Preventive Services Task Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778-786. Doi:10.7326/M15-2223
15. Bibbins-Domingo K, Grossman DC, Curry SJ, et al; US Preventive Services Task Force. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA. 2016;316(19): 1997-2007. Doi:10.1001/jama.2016.15450
16. Siu AL; U.S. Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(8):622-634. Doi:10.7326/M15-2023
17. Bibbins-Domingo K; U.S. Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(12):836-845. Doi:10.7326/M16-0577
18. LeFevre ML; U.S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 161(8):587-593. Doi:10.7326/M14-1796
19. Grossman DC, Bibbins-Domingo K, Curry SJ, et al; US Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement. JAMA. 2017;318(2):167-174. Doi:10.1001/jama.2017.7171
20. Grossman DC, Bibbins-Domingo K, Curry SJ, et al; US Preventive Services Task Force. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(23):2417-2426. Doi:10.1001/jama.2017.6803
21. Community Preventive Services Task Force (CPSTF). CPSTF findings for obesity. The Community Guide website. Https://www .thecommunityguide.org/content/task-force-findings-obesity. Accessed July 31, 2018.
22. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311(8):806-814. Doi:10.1001/jama.2014.732
23. National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-term Trends in Health. Hyattsville, MD: National Center for Health Statistics; 2017. Report 2017-1232.
24. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315 (21):2284-2291. Doi:10.1001/jama.2016.6458
25. Echeverria SE, MustafaM, Pentakota SR, et al. Social and clinically-relevant cardiovascular risk factors in Asian American adults: NHANES 2011-2014. Prev Med. 2017;99:222-227. Doi:10.1016/j.ypmed.2017.02.016
26. LeBlanc EL, Patnode CD,Webber EM, Redmond N, Rushkin M, O'Connor EA. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: evidence report and systematic review for the US Preventive Services Task Force [published September 18, 2018]. JAMA. Doi:10.1001/jama .2018.7777
27. KnowlerWC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. Doi:10.1056/NEJMoa012512
28. Tuomilehto J, Lindström J, Eriksson JG, et al; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350. Doi:10.1056/NEJM200105033441801
29. Lindström J, Peltonen M, Eriksson JG, et al; Finnish Diabetes Prevention Study (DPS). Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2013;56(2):284-293. Doi:10.1007/s00125-012-2752-5
30. Ochner CN, Barrios DM, Lee CD, Pi-Sunyer FX. Biological mechanisms that promote weight regain followingweight loss in obese humans. Physiol Behav. 2013;120:106-113. Doi:10.1016/j.physbeh.2013.07.009
31. Rosenbaum M, Kissileff HR,Mayer LE, Hirsch J, Leibel RL. Energy intake in weight-reduced humans. Brain Res. 2010;1350:95-102. Doi:10.1016/j .brainres.2010.05.062
32. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res. 1998;6(suppl 2):51S-209S. Doi:10.1002/j.1550-8528.1998.tb00690.x
33. Moyer VA; U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157(5):373-378.
34. Brauer P, Connor Gorber S, Shaw E, et al; Canadian Task Force on Preventive Health Care. Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care. CMAJ. 2015;187(3):184-195. Doi:10.1503/cmaj.140887
35. Jortberg B, Myers E, Gigliotti L, et al. Academy of Nutrition and Dietetics: standards of practice and standards of professional performance for registered dietitian nutritionists (competent, proficient, and expert) in adult weight management. J Acad Nutr Diet. 2015;115(4):609-618. Doi:10.1016/j.jand.2014.12.018
36. Jensen MD, Ryan DH, Apovian CM, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J AmColl Cardiol. 2014;63(25, pt B):2985-3023. Doi:10.1016/j.jacc.2013.11.004
37. GarveyWT, Garber AJ, Mechanick JI, et al; The Aace Obesity Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014;20(9):977-989. Doi:10.4158/EP14280.PS
38. Stegenga H, Haines A, Jones K, Wilding J; Guideline Development Group. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ. 2014;349:g6608. Doi:10.1136/bmj.g6608
39. American Academy of Family Physicians (AAFP). Clinical Preventive Service Recommendation: obesity. AAFP website. Https://www.aafp.org/patient-care/clinical-recommendations/all/obesity.html. Accessed July 31, 2018.